Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Javitt

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Molecular Psychiatry|March 1, 1996
Glutamate receptors and schizophrenia: opportunities and caveatsD C Javitt
Biological Psychiatry|October 1, 1996
Glycine therapy of schizophreniaD C Javitt
The Hillside Journal of Clinical Psychiatry|January 1, 1987
Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophreniaD C Javitt
Audiology & Neuro-Otology|June 22, 2000
Intracortical mechanisms of mismatch negativity dysfunction in schizophreniaD C Javitt
Current Psychiatry Reports|September 18, 2001
Management of negative symptoms of schizophreniaD C Javitt
Current Psychiatry Reports|December 21, 2000
Treatment of negative and cognitive symptomsD C Javitt
Molecular Psychiatry|July 28, 2004
Glutamate as a therapeutic target in psychiatric disordersD C Javitt
Psychopharmacology|January 1, 1997
Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuseD C Javitt, M Frusciante
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1990
The role of excitatory amino acids in neuropsychiatric illnessD C Javitt, S R Zukin
NIDA Research Monograph|January 1, 1993
Phencyclidine receptor binding as a probe of NMDA receptor functioning: implications for drug abuse researchS R Zukin, D C Javitt
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Molecular Psychiatry|March 1, 1996
Glutamate receptors and schizophrenia: opportunities and caveatsD C Javitt
Biological Psychiatry|October 1, 1996
Glycine therapy of schizophreniaD C Javitt
The Hillside Journal of Clinical Psychiatry|January 1, 1987
Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophreniaD C Javitt
Audiology & Neuro-Otology|June 22, 2000
Intracortical mechanisms of mismatch negativity dysfunction in schizophreniaD C Javitt
Current Psychiatry Reports|September 18, 2001
Management of negative symptoms of schizophreniaD C Javitt
Current Psychiatry Reports|December 21, 2000
Treatment of negative and cognitive symptomsD C Javitt
Molecular Psychiatry|July 28, 2004
Glutamate as a therapeutic target in psychiatric disordersD C Javitt
Psychopharmacology|January 1, 1997
Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuseD C Javitt, M Frusciante
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1990
The role of excitatory amino acids in neuropsychiatric illnessD C Javitt, S R Zukin
NIDA Research Monograph|January 1, 1993
Phencyclidine receptor binding as a probe of NMDA receptor functioning: implications for drug abuse researchS R Zukin, D C Javitt
Pageof 10